<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1537" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1537/" /><meta name="ncbi_pagename" content="Autosomal Dominant Epilepsy with Auditory Features - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Autosomal Dominant Epilepsy with Auditory Features - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Autosomal Dominant Epilepsy with Auditory Features" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/01/10" /><meta name="citation_author" content="Roberto Michelucci" /><meta name="citation_author" content="Carlo Nobile" /><meta name="citation_pmid" content="20301709" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1537/" /><meta name="citation_keywords" content="ADEAF" /><meta name="citation_keywords" content="Autosomal Dominant Lateral Temporal Epilepsy (ADLTE)" /><meta name="citation_keywords" content="ADEAF" /><meta name="citation_keywords" content="Autosomal Dominant Lateral Temporal Epilepsy (ADLTE)" /><meta name="citation_keywords" content="[F-actin]-monooxygenase MICAL1" /><meta name="citation_keywords" content="Leucine-rich glioma-inactivated protein 1" /><meta name="citation_keywords" content="Reelin" /><meta name="citation_keywords" content="LGI1" /><meta name="citation_keywords" content="MICAL1" /><meta name="citation_keywords" content="RELN" /><meta name="citation_keywords" content="Autosomal Dominant Epilepsy with Auditory Features" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Autosomal Dominant Epilepsy with Auditory Features" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Roberto Michelucci" /><meta name="DC.Contributor" content="Carlo Nobile" /><meta name="DC.Date" content="2019/01/10" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1537/" /><meta name="description" content="Autosomal dominant epilepsy with auditory features (ADEAF) is a focal epilepsy syndrome with auditory symptoms and/or receptive aphasia as prominent ictal manifestations. The most common auditory symptoms are simple unformed sounds including humming, buzzing, or ringing; less common forms are distortions (e.g., volume changes) or complex sounds (e.g., specific songs or voices). Ictal receptive aphasia consists of a sudden onset of inability to understand language in the absence of general confusion. Less commonly, other ictal symptoms may occur, including sensory symptoms (visual, olfactory, vertiginous, or cephalic) or motor, psychic, and autonomic symptoms. Most affected individuals have focal to bilateral tonic-clonic seizures, usually accompanied by &quot;focal aware&quot; and &quot;focal impaired-awareness&quot; seizures, with auditory symptoms as a major focal aware seizure manifestation. Some persons have seizures precipitated by sounds such as a ringing telephone. Age at onset is usually in adolescence or early adulthood (range: age 4-50 years). The clinical course of ADEAF is benign. Seizures are usually well controlled after initiation of medical therapy." /><meta name="og:title" content="Autosomal Dominant Epilepsy with Auditory Features" /><meta name="og:type" content="book" /><meta name="og:description" content="Autosomal dominant epilepsy with auditory features (ADEAF) is a focal epilepsy syndrome with auditory symptoms and/or receptive aphasia as prominent ictal manifestations. The most common auditory symptoms are simple unformed sounds including humming, buzzing, or ringing; less common forms are distortions (e.g., volume changes) or complex sounds (e.g., specific songs or voices). Ictal receptive aphasia consists of a sudden onset of inability to understand language in the absence of general confusion. Less commonly, other ictal symptoms may occur, including sensory symptoms (visual, olfactory, vertiginous, or cephalic) or motor, psychic, and autonomic symptoms. Most affected individuals have focal to bilateral tonic-clonic seizures, usually accompanied by &quot;focal aware&quot; and &quot;focal impaired-awareness&quot; seizures, with auditory symptoms as a major focal aware seizure manifestation. Some persons have seizures precipitated by sounds such as a ringing telephone. Age at onset is usually in adolescence or early adulthood (range: age 4-50 years). The clinical course of ADEAF is benign. Seizures are usually well controlled after initiation of medical therapy." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1537/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/peaf/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1537/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE888EB0DFC89A810000000005570268.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1537_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1537_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/alps/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/higes/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1537_"><span class="title" itemprop="name">Autosomal Dominant Epilepsy with Auditory Features</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: ADEAF, Autosomal Dominant Lateral Temporal Epilepsy (ADLTE)</div><p class="contrib-group"><span itemprop="author">Roberto Michelucci</span>, MD, PhD and <span itemprop="author">Carlo Nobile</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1537_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1537_ai__"><div class="contrib half_rhythm"><span itemprop="author">Roberto Michelucci</span>, MD, PhD<div class="affiliation small">Chief of Neurology, IRCCS Institute of Neurological Sciences<br />Neurology Unit<br />Bellaria Hospital<br />Bologna, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.bnsi@icculehcim.otrebor" class="oemail">ti.bnsi@icculehcim.otrebor</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Carlo Nobile</span>, PhD<div class="affiliation small">Senior Research Scientist, CNR Institute of Neuroscience<br />Padua, Italy</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 20, 2007</span>; Last Update: <span itemprop="dateModified">January 10, 2019</span>.</p><p><em>Estimated reading time: 29 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="peaf.Summary" itemprop="description"><h2 id="_peaf_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Autosomal dominant epilepsy with auditory features (ADEAF) is a focal epilepsy syndrome with auditory symptoms and/or receptive aphasia as prominent ictal manifestations. The most common auditory symptoms are simple unformed sounds including humming, buzzing, or ringing; less common forms are distortions (e.g., volume changes) or complex sounds (e.g., specific songs or voices). Ictal receptive aphasia consists of a sudden onset of inability to understand language in the absence of general confusion. Less commonly, other ictal symptoms may occur, including sensory symptoms (visual, olfactory, vertiginous, or cephalic) or motor, psychic, and autonomic symptoms. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have focal to bilateral tonic-clonic seizures, usually accompanied by "focal aware" and "focal impaired-awareness" seizures, with auditory symptoms as a major focal aware seizure manifestation. Some persons have seizures precipitated by sounds such as a ringing telephone. Age at onset is usually in adolescence or early adulthood (range: age 4-50 years). The clinical course of ADEAF is benign. Seizures are usually well controlled after initiation of medical therapy.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The clinical diagnosis of ADEAF is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical features, normal brain imaging (MRI or CT), and family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>LGI1</i>, <i>MICAL1</i>, <i>or RELN</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> establishes the diagnosis if other findings are inconclusive.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Seizure control is usually readily achieved with antiepileptic drugs used routinely in clinical practice (including but not limited to carbamazepine, phenytoin, valproate, and levetiracetam).</p><p><i>Evaluation of relatives at risk:</i> Interviewing relatives at risk to identify those with suggestive findings may enable early treatment in those who develop seizures.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ADEAF is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals with ADEAF have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; the proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is believed to be very low. Each child of an individual with ADEAF has a 50% chance of inheriting the pathogenic variant. The chance that the offspring who inherits the pathogenic variant will manifest ADEAF is between 55% and 78%, depending on the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. While <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the pathogenic variant in the family is known, prenatal testing and preimplantation genetic diagnosis are rarely requested for conditions that (like ADEAF) do not affect intellect and are usually easily treated.</p></div></div><div id="peaf.Diagnosis"><h2 id="_peaf_Diagnosis_">Diagnosis</h2><div id="peaf.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Autosomal dominant epilepsy with auditory features (ADEAF) <b>should be suspected</b> in individuals with the following clinical, imaging, and EEG findings and family history.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>A history consistent with focal epilepsy</b> from the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and witnesses. Other causes of epilepsy (e.g., antecedent illness or injury to the central nervous system, such as severe head trauma, stroke, and brain tumor) must be excluded.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Auditory symptoms</b> that occur in temporal association with seizures as one of the following:</div><ul><li class="half_rhythm"><div>An aura immediately preceding generalized tonic-clonic convulsions</div></li><li class="half_rhythm"><div>A component of focal aware or focal impaired-awareness seizures</div></li><li class="half_rhythm"><div>The only ictal symptom</div></li></ul><div class="half_rhythm">Note: Auditory symptoms may be underreported; therefore, specific questions to elicit occurrence of auditory symptoms should be included in the clinical history. Since tinnitus and other auditory disturbances may be reported as incidental findings in a person with epilepsy, care should be taken in obtaining the medical history to document a consistent temporal association of auditory symptoms with seizure events or to raise a strong suspicion of the ictal nature of the auditory symptom if not associated with other clinical features.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Aphasia</b> that accompanies seizure onset. Aphasia may be difficult to distinguish from nonspecific confusion or alteration of consciousness; therefore, specific questions to assess the inability to understand spoken language in the absence of general confusion should be included in the clinical history. Note: Persons with epilepsy may report the inability to comprehend speech at the onset of seizures as a result of nonspecific confusion or alteration in consciousness; thus, care should be taken in obtaining the medical history to distinguish this confusion from specific symptoms of aphasia (i.e., an inability to understand language in the absence of alteration in consciousness).</div></li></ul><p><b>Brain imaging</b>
<b>(MRI or CT).</b> Normal</p><p><b>Interictal EEG.</b> Often normal. However, focal epileptiform abnormalities (usually localized to the temporal region) are found in up to two thirds of individuals.</p><p><b>Family history.</b> Consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance (with reduced and age-dependent <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>).Two or more family members (including the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>) must have a history of focal epilepsy with either ictal auditory symptoms or ictal aphasia. Other family members may have different seizure types, usually tonic-clonic (undetermined whether focal or generalized).</p></div><div id="peaf.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The clinical diagnosis of ADEAF <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the above clinical features, normal brain imaging studies (MRI or CT), and family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>LGI1</i>, <i>MICAL1</i>, <i>or RELN</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (<a class="figpopup" href="/books/NBK1537/table/peaf.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figpeafTmoleculargenetictestingusedin" rid-ob="figobpeafTmoleculargenetictestingusedin">Table 1</a>) establishes the diagnosis if other findings are inconclusive.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>LGI1</i>, <i>MICAL1</i>, <i>RELN</i>, and other genes of interest (see <a href="#peaf.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1537/table/peaf.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figpeafTmoleculargenetictestingusedin" rid-ob="figobpeafTmoleculargenetictestingusedin">Table 1</a>).</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>Note:</b> Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing of <i>LGI1</i>, <i>MICAL1</i>, and <i>RELN</i> is impractical given the relatively large number of exons in the latter two genes.</p><div id="peaf.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Autosomal Dominant Epilepsy with Auditory Features</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1537/table/peaf.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__peaf.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of ADEAF&#x000a0;<sup>3</sup> Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>4</sup> in This Gene Detectable by This Method</th></tr><tr><th headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></th><th headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></th></tr></thead><tbody><tr><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LGI1</i></td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30%&#x000a0;<sup>7</sup></td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95%</td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MICAL1</i></td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7%&#x000a0;<sup>9</sup></td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%-95%</td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RELN</i></td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17%-18%&#x000a0;<sup>7</sup></td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%-95%%&#x000a0;<sup>10</sup></td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~50%</td><td headers="hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_peaf.T.molecular_genetic_testing_used_in_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="peaf.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="peaf.TF.1.2"><p class="no_margin">See <a href="/books/NBK1537/#peaf.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="peaf.TF.1.3"><p class="no_margin">Autosomal dominant inheritance defined as &#x02265;2 family members with <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> focal epilepsy with ictal auditory symptoms or receptive aphasia [<a class="bk_pop" href="#peaf.REF.michelucci.2003.1289">Michelucci et al 2003</a>, <a class="bk_pop" href="#peaf.REF.berkovic.2004a.1115">Berkovic et al 2004a</a>, <a class="bk_pop" href="#peaf.REF.ottman.2004.1120">Ottman et al 2004</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2013.1288">Michelucci et al 2013</a>].</p></div></dd><dt>4. </dt><dd><div id="peaf.TF.1.4"><p class="no_margin">See <a href="#peaf.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in these genes.</p></div></dd><dt>5. </dt><dd><div id="peaf.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="peaf.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="peaf.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#peaf.REF.michelucci.2017.103">Michelucci et al [2017]</a></p></div></dd><dt>8. </dt><dd><div id="peaf.TF.1.8"><p class="no_margin">A <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> encompassing the first four exons of <i>LGI1</i> was identified in one family [<a class="bk_pop" href="#peaf.REF.fanciulli.2012.1299">Fanciulli et al 2012</a>], and a deletion encompassing the second <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> in another family [<a class="bk_pop" href="#peaf.REF.dazzo.2015b.132">Dazzo et al 2015b</a>]. No structural variants were identified by MLPA in 43 other families [<a class="bk_pop" href="#peaf.REF.magini.2014.972">Magini et al 2014</a>, <a class="bk_pop" href="#peaf.REF.manna.2014.597">Manna et al 2014</a>, <a class="bk_pop" href="#peaf.REF.dazzo.2015b.132">Dazzo et al 2015b</a>].</p></div></dd><dt>9. </dt><dd><div id="peaf.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#peaf.REF.dazzo.2018.483">Dazzo et al [2018]</a></p></div></dd><dt>10. </dt><dd><div id="peaf.TF.1.10"><p class="no_margin"><a class="bk_pop" href="#peaf.REF.dazzo.2015a.992">Dazzo et al [2015a]</a></p></div></dd><dt>11. </dt><dd><div id="peaf.TF.1.11"><p class="no_margin">A <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> on 19q13.11-q13.31 likely to harbor a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> associated with ADEAF was identified in a large Brazilian family [<a class="bk_pop" href="#peaf.REF.bisulli.2014.841">Bisulli et al 2014</a>]. In 21 families with ADEAF, 12 rare CNVs were identified by genome-wide SNP microarray analysis that segregated with ADEAF in single families, including rare microdeletions within or near <i>RBFOX1</i> and <i>NRXN1</i>, and a microduplication in the proximal region of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 1q21.1, where duplications have been associated with various neurodevelopmental disorders and epilepsy [<a class="bk_pop" href="#peaf.REF.fanciulli.2014.1651">Fanciulli et al 2014</a>]. Deletions/duplications at these loci confer susceptibility to other forms of genetic epilepsy.</p></div></dd></dl></div></div></div></div></div><div id="peaf.Clinical_Characteristics"><h2 id="_peaf_Clinical_Characteristics_">Clinical Characteristics</h2><div id="peaf.Clinical_Description"><h3>Clinical Description</h3><p>Autosomal dominant epilepsy with auditory features (ADEAF) is characterized by focal epilepsy not caused by a previous illness or injury, with auditory symptoms and/or receptive aphasia as prominent ictal manifestations. Age at onset has ranged from four to 50 years in previously reported families [<a class="bk_pop" href="#peaf.REF.winawer.2000.2173">Winawer et al 2000</a>, <a class="bk_pop" href="#peaf.REF.brodtkorb.2002.228">Brodtkorb et al 2002</a>, <a class="bk_pop" href="#peaf.REF.winawer.2002.60">Winawer et al 2002</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2003.1289">Michelucci et al 2003</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2013.1288">Michelucci et al 2013</a>], but is usually in adolescence or early adulthood. The prominent auditory symptoms and aphasia are thought to reflect a localization of the epileptogenic zone in the lateral temporal lobe; accordingly, ADEAF is also known as <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> lateral temporal epilepsy (ADLTE).</p><p><b>Epilepsy.</b> Affected individuals have focal to bilateral tonic-clonic seizures, usually accompanied by focal aware or focal impaired-awareness seizures, with auditory symptoms as a major focal aware seizure manifestation occurring in around two thirds of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Some individuals have seizures precipitated by specific sounds, such as a telephone ringing [<a class="bk_pop" href="#peaf.REF.michelucci.2003.1289">Michelucci et al 2003</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2004.280">Michelucci et al 2004</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2007.2150">Michelucci et al 2007</a>].</p><p>Although most individuals in families with ADEAF have focal epilepsy, <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> generalized epilepsy was reported in four individuals with <i>LGI1</i> pathogenic variants in two previously reported families [<a class="bk_pop" href="#peaf.REF.ottman.2004.1120">Ottman et al 2004</a>]. The occurrence of idiopathic generalized epilepsies in these families may be explained either as an effect of <i>LGI1</i> on the risk for idiopathic generalized epilepsy, or by the co-occurring <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in these families of another (unidentified) <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> that specifically influences risk for idiopathic generalized epilepsy.</p><p>Febrile seizures do not occur with increased frequency in ADEAF.</p><p><b>Auditory symptoms.</b> The most common auditory symptoms are simple unformed sounds such as humming, buzzing, or ringing. Less frequently, other types of auditory symptoms occur, including complex sounds (e.g., specific songs or voices) or distortions (e.g., volume changes). Negative auditory symptoms, such as sudden decrease or disappearance of the surrounding noises, are reported by a minority of patients.</p><p><b>Aphasia.</b> Another distinctive feature is ictal receptive aphasia (i.e., sudden onset of an inability to understand language, in the absence of general confusion). Ictal aphasia was the most prominent symptom in one large Norwegian family with an <i>LGI1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#peaf.REF.brodtkorb.2002.228">Brodtkorb et al 2002</a>, <a class="bk_pop" href="#peaf.REF.brodtkorb.2005a.963">Brodtkorb et al 2005a</a>] (although auditory symptoms also occurred) and in a small Japanese family [<a class="bk_pop" href="#peaf.REF.kanemoto.2000.1036">Kanemoto &#x00026; Kawasaki 2000</a>]. Aphasia has also been reported in other families with <i>LGI1</i> pathogenic variants [<a class="bk_pop" href="#peaf.REF.michelucci.2003.1289">Michelucci et al 2003</a>, <a class="bk_pop" href="#peaf.REF.ottman.2004.1120">Ottman et al 2004</a>, <a class="bk_pop" href="#peaf.REF.di_bonaventura.2009.2481">Di Bonaventura et al 2009</a>].</p><p><b>Other ictal symptoms.</b> In families with ADEAF, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals also have other ictal symptoms, either in isolation or accompanying auditory symptoms or aphasia. These occur less frequently than auditory symptoms and include other sensory symptoms (visual, olfactory, vertiginous, or cephalic) as well as motor, psychic, and autonomic symptoms [<a class="bk_pop" href="#peaf.REF.poza.1999.182">Poza et al 1999</a>, <a class="bk_pop" href="#peaf.REF.winawer.2000.2173">Winawer et al 2000</a>, <a class="bk_pop" href="#peaf.REF.winawer.2002.60">Winawer et al 2002</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2003.1289">Michelucci et al 2003</a>, <a class="bk_pop" href="#peaf.REF.hedera.2004.218">Hedera et al 2004</a>, <a class="bk_pop" href="#peaf.REF.ottman.2004.1120">Ottman et al 2004</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2013.1288">Michelucci et al 2013</a>, <a class="bk_pop" href="#peaf.REF.dazzo.2015b.132">Dazzo et al 2015b</a>].</p><p><b>Non-epileptic manifestations</b> associated with ADEAF on rare occasion include the following:</p><ul><li class="half_rhythm"><div>Behavioral problems (e.g., explosive violent behaviors, impulsiveness) and depression (with suicide attempts) have been reported in single pedigrees [<a class="bk_pop" href="#peaf.REF.chabrol.2007.217">Chabrol et al 2007</a>, <a class="bk_pop" href="#peaf.REF.kawamata.2010.690">Kawamata et al 2010</a>]. However, a systematic study investigating a possible shared genetic susceptibility to epilepsy and depression in families with an <i>LGI1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> did not find such an association; rather, the depression appeared to be related to the epilepsy or antiepileptic treatment [<a class="bk_pop" href="#peaf.REF.heiman.2010.1685">Heiman et al 2010</a>].</div></li><li class="half_rhythm"><div>Migraine segregating with occipito-temporal epilepsy resembling ADEAF has been described in one family [<a class="bk_pop" href="#peaf.REF.deprez.2007.1995">Deprez et al 2007</a>].</div></li></ul><p><b>Prognosis.</b> The clinical course of ADEAF is usually benign. The following are offered as examples.</p><ul><li class="half_rhythm"><div>In a series of 34 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in seven Spanish and Italian families, focal to bilateral tonic-clonic seizures occurred only once or twice per year. The frequency of focal aware or focal impaired-awareness seizures ranged from twice per year to several times per month. After initiation of medical therapy, seizures were well controlled by any of a variety of medications (carbamazepine, phenobarbital, or phenytoin), sometimes at low doses [<a class="bk_pop" href="#peaf.REF.michelucci.2003.1289">Michelucci et al 2003</a>].</div></li><li class="half_rhythm"><div>In a Norwegian family with prominent ictal aphasia, all individuals had been free from focal to bilateral tonic-clonic seizures for two or more years, and focal aware seizures occurred infrequently in most individuals. However, two family members with epilepsy died suddenly in their sleep, both at age 28 years; a relationship to seizures was suspected but could not be confirmed [<a class="bk_pop" href="#peaf.REF.brodtkorb.2002.228">Brodtkorb et al 2002</a>].</div></li><li class="half_rhythm"><div>In one other family with an <i>LGI1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, an unusual clinical picture with high seizure frequency and antiepileptic drug resistance was described [<a class="bk_pop" href="#peaf.REF.di_bonaventura.2009.2481">Di Bonaventura et al 2009</a>].</div></li></ul><p><b>EEG.</b> Interictal (routine and sleep-deprived) EEGs may be normal in persons with ADEAF; however, epileptiform interictal EEG abnormalities are found in up to two thirds of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#peaf.REF.poza.1999.182">Poza et al 1999</a>, <a class="bk_pop" href="#peaf.REF.winawer.2000.2173">Winawer et al 2000</a>, <a class="bk_pop" href="#peaf.REF.brodtkorb.2002.228">Brodtkorb et al 2002</a>, <a class="bk_pop" href="#peaf.REF.winawer.2002.60">Winawer et al 2002</a>, <a class="bk_pop" href="#peaf.REF.fertig.2003.1687">Fertig et al 2003</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2003.1289">Michelucci et al 2003</a>, <a class="bk_pop" href="#peaf.REF.pizzuti.2003.396">Pizzuti et al 2003</a>, <a class="bk_pop" href="#peaf.REF.hedera.2004.218">Hedera et al 2004</a>, <a class="bk_pop" href="#peaf.REF.ottman.2004.1120">Ottman et al 2004</a>, <a class="bk_pop" href="#peaf.REF.pisano.2005.118">Pisano et al 2005</a>]. Interestingly, a left predominance of the abnormalities has been observed in some clinical series [<a class="bk_pop" href="#peaf.REF.michelucci.2003.1289">Michelucci et al 2003</a>, <a class="bk_pop" href="#peaf.REF.di_bonaventura.2009.2481">Di Bonaventura et al 2009</a>].</p><p>Ictal EEGs have been reported in three persons [<a class="bk_pop" href="#peaf.REF.winawer.2002.60">Winawer et al 2002</a>, <a class="bk_pop" href="#peaf.REF.brodtkorb.2005a.963">Brodtkorb et al 2005a</a>, <a class="bk_pop" href="#peaf.REF.di_bonaventura.2009.2481">Di Bonaventura et al 2009</a>]. One of these showed left mid- and anterior temporal onset [<a class="bk_pop" href="#peaf.REF.winawer.2002.60">Winawer et al 2002</a>], and another onset in the left frontotemporal region with bilateral and posterior spreading, documented during a video-recorded aphasic seizure [<a class="bk_pop" href="#peaf.REF.brodtkorb.2005a.963">Brodtkorb et al 2005a</a>]. The third was recorded during a prolonged seizure cluster lasting several hours in an individual with prominent ictal aphasia; the EEG pattern consisted of low-voltage fast activity followed by delta activity and rhythmic sharp waves located in the anterior and middle left temporal regions [<a class="bk_pop" href="#peaf.REF.di_bonaventura.2009.2481">Di Bonaventura et al 2009</a>].</p><p>Findings from magnetoencephalography (MEG) with auditory stimuli showed significantly delayed peak 2 auditory evoked field latency in individuals with <i>LGI1</i> pathogenic variants [<a class="bk_pop" href="#peaf.REF.ottman.2008.1973">Ottman et al 2008</a>]. Another study using MEG detected significantly large N100m signals in three of five individuals, contralateral to the auditory stimulation [<a class="bk_pop" href="#peaf.REF.usui.2009.1923">Usui et al 2009</a>].</p><p><b>Neuroimaging.</b> Findings from routine neurologic examination and routine clinical imaging (MRI or CT) are normal.</p><p>An interictal single-photon emission computed tomographic scan in one person identified hypoperfusion in the left temporal lobe [<a class="bk_pop" href="#peaf.REF.poza.1999.182">Poza et al 1999</a>].</p><p>A left lateral temporal lobe malformation was identified through high-resolution MRI in ten individuals in a Brazilian family with an <i>LGI1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#peaf.REF.kobayashi.2003.1546">Kobayashi et al 2003</a>]. However, other studies using high-resolution MRI in families with <i>LGI1</i> pathogenic variants have not confirmed this finding [<a class="bk_pop" href="#peaf.REF.tessa.2007.1298">Tessa et al 2007</a>, <a class="bk_pop" href="#peaf.REF.ottman.2008.1973">Ottman et al 2008</a>].</p><p>Diffusion tensor imaging identified a region of increased fractional anisotropy in the left temporal lobe in individuals with an <i>LGI1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#peaf.REF.tessa.2007.1298">Tessa et al 2007</a>].</p><p>In functional MRI with an auditory description decision task, persons with epilepsy in families with an <i>LGI1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had significantly less activation than controls [<a class="bk_pop" href="#peaf.REF.ottman.2008.1973">Ottman et al 2008</a>]. These results suggest that individuals with ADEAF have functional impairment in language processing.</p><p><b>Other investigations.</b> Asymmetry of long-latency auditory evoked potentials (with reduced left N1-P2 amplitudes) was shown in the Norwegian family with aphasic seizures [<a class="bk_pop" href="#peaf.REF.brodtkorb.2005b.1692">Brodtkorb et al 2005b</a>]. Abnormal phonologic processing was demonstrated in four persons in a Sardinian family by means of a fused dichotic listening task [<a class="bk_pop" href="#peaf.REF.pisano.2005.118">Pisano et al 2005</a>]. The above data, though based on a small sample size, would appear to suggest the existence of some structural abnormalities in the lateral temporal neuronal network.</p></div><div id="peaf.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Auditory symptoms were less frequent with <i>LGI1</i> pathogenic variants that predict truncation in the terminal epitempin repeat <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> than with other <i>LGI1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> type/domain combinations [<a class="bk_pop" href="#peaf.REF.ho.2012.563">Ho et al 2012</a>].</p><p>Phenotypic features are the same in published <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases with <i>LGI1</i>, <i>MICAL1</i>, or <i>RELN</i> pathogenic variants [<a class="bk_pop" href="#peaf.REF.dazzo.2015a.992">Dazzo et al 2015a</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2017.103">Michelucci et al 2017</a>, <a class="bk_pop" href="#peaf.REF.dazzo.2018.483">Dazzo et al 2018</a>].</p><p>No significant clinical differences are observed between families with an <i>LGI1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and families without an identified pathogenic variant [Michelucci e al 2013].</p><p>No phenotypic differences have been found between <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) and published <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases [<a class="bk_pop" href="#peaf.REF.bisulli.2004a.1343">Bisulli et al 2004a</a>, <a class="bk_pop" href="#peaf.REF.bisulli.2004b.455">Bisulli et al 2004b</a>, <a class="bk_pop" href="#peaf.REF.flex.2005.62">Flex et al 2005</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2007.2150">Michelucci et al 2007</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2009.52">Michelucci et al 2009</a>].</p></div><div id="peaf.Penetrance"><h3>Penetrance</h3><p>Estimates of <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in studies of families with ADEAF range from 54% to 85% [<a class="bk_pop" href="#peaf.REF.ottman.1995.56">Ottman et al 1995</a>, <a class="bk_pop" href="#peaf.REF.poza.1999.182">Poza et al 1999</a>, <a class="bk_pop" href="#peaf.REF.ottman.2004.1120">Ottman et al 2004</a>, <a class="bk_pop" href="#peaf.REF.wang.2006.1081">Wang et al 2006</a>]. This variability may in part result from the use of different statistical models.</p><p><b><i>LGI1</i>.</b> Based on analysis of obligate heterozygotes in 24 published families, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <i>LGI1</i> pathogenic variants was estimated at 67% (95% CI 55%-77%) [<a class="bk_pop" href="#peaf.REF.rosanoff.2008.567">Rosanoff &#x00026; Ottman 2008</a>].</p><p>More recently, in a study of 33 families in which probands were excluded, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for epilepsy was estimated at 61% in ten families with an <i>LGI1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and 35% in families without an identified pathogenic variant, suggesting that inheritance may be complex in some families [<a class="bk_pop" href="#peaf.REF.michelucci.2013.1288">Michelucci et al 2013</a>].</p><p>All of these estimates are likely to be inflated by ascertainment bias, since they are based on families selected for study because they comprised many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><b><i>RELN</i>.</b> Twenty (60%) of 33 individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>RELN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (from 7 families) had epilepsy [<a class="bk_pop" href="#peaf.REF.dazzo.2015a.992">Dazzo et al 2015a</a>].</p><p><b><i>MICAL1</i>.</b> Penetrance is unknown.</p></div><div id="peaf.Prevalence"><h3>Prevalence</h3><p>The prevalence of ADEAF is unknown but likely to be very low. Fewer than 3% of persons with epilepsy have a significant family history of epilepsy and only a fraction of these have clinical features consistent with ADEAF.</p><p>Whereas Mendelian epilepsy syndromes account for a very small fraction of all epilepsy, findings from one study suggest that among Mendelian forms of focal epilepsy, ADEAF may not be rare as 9/48 (19%) of families with two or more individuals with <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> focal epilepsy met criteria for ADEAF (i.e., they comprised &#x02265;2 individuals with ictal auditory symptoms) [<a class="bk_pop" href="#peaf.REF.ottman.2004.1120">Ottman et al 2004</a>].</p></div></div><div id="peaf.Genetically_Related_Allelic_Disorde"><h2 id="_peaf_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>LGI1</i> and <i>MICAL1.</i></p><p>Homozygous <i>RELN</i> pathogenic variants cause lissencephaly with cerebellar hypoplasia (OMIM <a href="http://omim.org/entry/257320" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">257320</a>), a recessive disorder characterized by severe and widespread neuronal migration defects, delayed cognitive development, and seizures [<a class="bk_pop" href="#peaf.REF.hong.2000.93">Hong et al 2000</a>].</p></div><div id="peaf.Differential_Diagnosis"><h2 id="_peaf_Differential_Diagnosis_">Differential Diagnosis</h2><p><a class="figpopup" href="/books/NBK1537/table/peaf.T.mendelian_focal_epilepsy_disorder/?report=objectonly" target="object" rid-figpopup="figpeafTmendelianfocalepilepsydisorder" rid-ob="figobpeafTmendelianfocalepilepsydisorder">Table 2</a> summarizes Mendelian focal epilepsy disorders. Distinguishing among these disorders can be challenging because the manifestations in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members are variable and no operational criteria for classification of families are yet available [<a class="bk_pop" href="#peaf.REF.picard.2000.1247">Picard et al 2000</a>]. Moreover, these different forms of focal epilepsy have shared genetic mechanisms; pathogenic variants in <i>DEPDC5</i> have been identified in all of them [<a class="bk_pop" href="#peaf.REF.poduri.2014.631">Poduri 2014</a>], and were found in ten (12%) of 82 families with two or more individuals with focal epilepsy who did not have a detectable structural etiology [<a class="bk_pop" href="#peaf.REF.dibbens.2013.546">Dibbens et al 2013</a>]. However, to date, pathogenic variants in <i>DEPDC5</i> have not been identified in families with ADEAF. (See also <a href="/books/n/gene/depdc5-epilepsy/"><i>DEPDC5-</i>Related Epilepsy</a>.)</p><div id="peaf.T.mendelian_focal_epilepsy_disorder" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Mendelian Focal Epilepsy Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1537/table/peaf.T.mendelian_focal_epilepsy_disorder/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__peaf.T.mendelian_focal_epilepsy_disorder_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4" colspan="6" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features</th></tr><tr><th headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4" id="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Localization of<br />epileptogenic<br />zone</th><th headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4" id="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizure semiology</th><th headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4" id="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Age at onset</th><th headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4" id="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuroimaging</th><th headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4" id="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EEG</th><th headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4" id="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other</th></tr></thead><tbody><tr><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Autosomal dominant epilepsy w/auditory features (ADEAF)</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LGI1</i><br /><i>MICAL1</i><br /><i>RELN</i></td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lateral temporal</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Auditory symptoms are most common.</div></li><li class="half_rhythm"><div>Autonomic or psychic symptoms occur in &#x0003c;25% of individuals.&#x000a0;<sup>1</sup></div></li></ul>
</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually late adolescence or early adulthood</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Interictal EEGs may be normal.</div></li><li class="half_rhythm"><div>Epileptiform interictal EEG abnormalities found in &#x02264;2/3s of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals&#x000a0;<sup>2</sup></div></li><li class="half_rhythm"><div>Ictal EEGs reported in 3 persons&#x000a0;<sup>3</sup></div></li></ul>
</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/adnfle/">Autosomal dominant nocturnal frontal lobe epilepsy</a> (ADNFLE)</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRNA4</i><br /><i>CHRNB2</i><br /><i>CHRNA2</i><br /><i>KCNT1</i><br /><i>DEPDC5</i><br /><i>CRH</i>&#x000a0;<sup>4</sup></td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontal lobe (rarely from extrafrontal areas - e.g., temporal, insular, &#x00026; parietal regions)</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Asymmetric tonic/dystonic posturing &#x00026;/or complex hyperkinetic seizures, mostly during sleep</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1st 2 decades of life in ~80% (mean age of onset 10 yrs)</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Interictal &#x00026; ictal scalp EEG features may be normal.</div></li><li class="half_rhythm"><div>Prolonged video-EEG recording is best diagnostic test to assess seizure occurrence.</div></li></ul>
</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Characterized by clusters of nocturnal motor seizures, often stereotyped &#x00026; brief (5 secs - 5 mins)</div></li><li class="half_rhythm"><div>Clinical neurologic exam normal &#x00026; intellect usually preserved, but psychiatric comorbidity or cognitive deficits may occur</div></li><li class="half_rhythm"><div>Manifestations may vary considerably w/in a family.</div></li></ul>
</td></tr><tr><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial mesial temporal lobe epilepsy (FMTLE)<br />(OMIM <a href="https://omim.org/phenotypicSeries/PS600512" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS600512</a>)</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mesial temporal lobe&#x000a0;<sup>5</sup></td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Psychic symptoms (esp. d&#x000e9;j&#x000e0; vu) most common</div></li><li class="half_rhythm"><div>Autonomic or special sensory components in ~50%</div></li><li class="half_rhythm"><div>Auditory symptoms in &#x0003c;10%</div></li></ul>
</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually late adolescence or early adulthood</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Interictal epileptiform EEG abnormalities in ~20%</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Febrile seizure frequency as in general population</div></li><li class="half_rhythm"><div>Benign clinical course, w/long remissions &#x00026; good response to range of therapies (carbamazepine, phenytoin, or valproate)</div></li></ul>
</td></tr><tr><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial partial epilepsy w/variable foci (FPEVF)<br />(OMIM <a href="https://omim.org/phenotypicSeries/PS604364" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS604364</a>)</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DEPDC5</i><br /><i>NPRL2</i><br /><i>NPRL3</i></td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Epileptogenic zone (frontal, temporal, or occipital) differs among family members.&#x000a0;<sup>6</sup></div></li><li class="half_rhythm"><div>Frontal lobe seizures most common</div></li></ul>
</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Auditory symptoms &#x00026; aphasia not described in families w/FPEVF</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually middle childhood to early adulthood</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Interictal &#x00026; ictal EEG abnormalities localized in different areas (frontal, temporal, occipital)</td><td headers="hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_1_4 hd_h_peaf.T.mendelian_focal_epilepsy_disorder_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures in FPEVF occur less frequently than in ADNFLE; when they occur it is more often in daytime.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="peaf.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#peaf.REF.ottman.2004.1120">Ottman et al [2004]</a></p></div></dd><dt>2. </dt><dd><div id="peaf.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#peaf.REF.poza.1999.182">Poza et al [1999]</a>, <a class="bk_pop" href="#peaf.REF.winawer.2000.2173">Winawer et al [2000]</a>, <a class="bk_pop" href="#peaf.REF.brodtkorb.2002.228">Brodtkorb et al [2002]</a>, <a class="bk_pop" href="#peaf.REF.winawer.2002.60">Winawer et al [2002]</a>, <a class="bk_pop" href="#peaf.REF.fertig.2003.1687">Fertig et al [2003]</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2003.1289">Michelucci et al [2003]</a>, <a class="bk_pop" href="#peaf.REF.pizzuti.2003.396">Pizzuti et al [2003]</a>, <a class="bk_pop" href="#peaf.REF.hedera.2004.218">Hedera et al [2004]</a>, <a class="bk_pop" href="#peaf.REF.ottman.2004.1120">Ottman et al [2004]</a>, <a class="bk_pop" href="#peaf.REF.pisano.2005.118">Pisano et al [2005]</a></p></div></dd><dt>3. </dt><dd><div id="peaf.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#peaf.REF.winawer.2002.60">Winawer et al [2002]</a>, <a class="bk_pop" href="#peaf.REF.brodtkorb.2005b.1692">Brodtkorb et al [2005b]</a>, <a class="bk_pop" href="#peaf.REF.di_bonaventura.2009.2481">Di Bonaventura et al [2009]</a></p></div></dd><dt>4. </dt><dd><div id="peaf.TF.2.4"><p class="no_margin">Molecular genetic testing reveals pathogenic variants in <i>CHRNA4</i>, <i>CHRNB2</i>, <i>CHRNA2</i>, <i>KCNT1</i>, <i>DEPDC5</i>, or <i>CRH</i> in approximately 20% of individuals with a positive family history and fewer than 5% of individuals with a negative family history.</p></div></dd><dt>5. </dt><dd><div id="peaf.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#peaf.REF.andermann.2005.61">Andermann et al [2005]</a></p></div></dd><dt>6. </dt><dd><div id="peaf.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#peaf.REF.scheffer.1998.890">Scheffer et al [1998]</a>, <a class="bk_pop" href="#peaf.REF.xiong.1999.1698">Xiong et al [1999]</a>, <a class="bk_pop" href="#peaf.REF.callenbach.2003.1298">Callenbach et al [2003]</a>, <a class="bk_pop" href="#peaf.REF.berkovic.2004b.1054">Berkovic et al [2004b]</a></p></div></dd></dl></div></div></div></div><div id="peaf.Management"><h2 id="_peaf_Management_">Management</h2><div id="peaf.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> epilepsy with auditory features (ADEAF), consultation with a clinical geneticist and/or genetic counselor is recommended.</p></div><div id="peaf.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>ADEAF is benign in the great majority of individuals. No clinical trials of different antiepileptic medications have been carried out, but seizure control is achieved in most individuals with medications used routinely in clinical practice (e.g., carbamazepine, phenytoin, valproate).</p><p>Education of parents regarding common seizure presentations is appropriate. For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child <u>Toolkit</u></a>.</p></div><div id="peaf.Surveillance"><h3>Surveillance</h3><p>No surveillance guidelines for ADEAF have been developed.</p><ul><li class="half_rhythm"><div>As in any other form of focal epilepsy, routine interictal EEG may be performed to detect focal epileptiform abnormalities.</div></li><li class="half_rhythm"><div>Brain MRI may be repeated to rule out structural abnormalities.</div></li></ul></div><div id="peaf.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment and measures to minimize risk in the event of seizure onset (e.g., avoidance of unattended swimming).</p><ul><li class="half_rhythm"><div>If the <i>LGI1</i>, <i>MICAL1</i>, or <i>RELN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk relatives.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known, interview of relatives at risk may identify symptoms possibly related to seizures.</div></li></ul><p>See <a href="#peaf.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="peaf.Pregnancy_Management"><h3>Pregnancy Management</h3><p>In general, women with epilepsy or a seizure disorder from any cause are at greater risk for mortality during pregnancy than pregnant women without a seizure disorder; use of antiepileptic medication during pregnancy reduces this risk. However, exposure to antiepileptic medication may increase the risk for adverse fetal outcome (depending on the drug used, the dose, and the stage of pregnancy at which medication is taken). Nevertheless, the risk of an adverse outcome to the fetus from antiepileptic medication exposure is often less than that associated with exposure to an untreated maternal seizure disorder. Therefore, use of antiepileptic medication to treat a maternal seizure disorder during pregnancy is typically recommended. Discussion of the risks and benefits of using a given antiepileptic drug during pregnancy should ideally take place prior to conception. Transitioning to a lower-risk medication prior to pregnancy may be possible [<a class="bk_pop" href="#peaf.REF.sarma.2016.467">Sarma et al 2016</a>].</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="peaf.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="peaf.Genetic_Counseling"><h2 id="_peaf_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="peaf.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Autosomal dominant epilepsy with auditory features (ADEAF) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="peaf.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with ADEAF have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with ADEAF may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>LGI1</i> or <i>RELN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; the proportion of cases caused by a <i>de novo</i> pathogenic variant is believed to be low (~1%).</div><ul><li class="half_rhythm"><div>Three (1%) of 230 <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) had a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>LGI1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#peaf.REF.bisulli.2004a.1343">Bisulli et al 2004a</a>, <a class="bk_pop" href="#peaf.REF.bisulli.2004b.455">Bisulli et al 2004b</a>, <a class="bk_pop" href="#peaf.REF.flex.2005.62">Flex et al 2005</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2007.2150">Michelucci et al 2007</a>, <a class="bk_pop" href="#peaf.REF.dazzo.2015b.132">Dazzo et al 2015b</a>]. Two were <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> [<a class="bk_pop" href="#peaf.REF.bisulli.2004b.455">Bisulli et al 2004b</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2007.2150">Michelucci et al 2007</a>]; the origin of the third could not be determined [<a class="bk_pop" href="#peaf.REF.dazzo.2015b.132">Dazzo et al 2015b</a>].</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified in a study of 16 Turkish <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases and ten <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases [<a class="bk_pop" href="#peaf.REF.kesim.2016.73">Kesim et al 2016</a>].</div></li></ul></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the parents and a medical history to ascertain a history of seizures.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with ADEAF may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of seizures, late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (e.g., <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> and/or clinical history) have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs of a proband depends on the clinical/genetic status of the parents:</p><ul><li class="half_rhythm"><div>If a parent has clinical characteristics consistent with ADEAF and/or has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, the likelihood that each sib will inherit the pathogenic variant is 50%. The chance that a sib who inherits the pathogenic variant will manifest ADEAF ranges from 54% to 85%, depending on the assumed <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. (See <a href="#peaf.Penetrance">Penetrance</a>.)</div></li><li class="half_rhythm"><div>If a parent has clinical characteristics consistent with ADEAF and does not have the <i>LGI1</i>, <i>MICAL1</i>, or <i>RELN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs might be as low as 35%, especially in small-sized (nuclear) families (see <a href="#peaf.Penetrance">Penetrance</a>.)</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known <i>LGI1</i>, <i>MICAL1</i>, or <i>RELN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#peaf.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the ADEAF-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. However, sibs of a proband with clinically unaffected parents are still presumed to be at increased risk for ADEAF because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Offspring of an individual with ADEAF who is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of inheriting the pathogenic variant; the chance that offspring who inherit the pathogenic variant will manifest ADEAF ranges from 54% to 85% depending on the assumed <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has phenotypic features consistent with ADEAF or has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>LGI1</i>, <i>MICAL1</i>, or <i>RELN</i>, his or her family members may be at risk.</p></div><div id="peaf.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#peaf.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p>Diagnostic testing for <i>LGI1</i>, <i>MICAL1</i>, or <i>RELN</i> pathogenic variants in individuals with ADEAF has limited clinical utility because identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> would not lead to a change in treatment or management [<a class="bk_pop" href="#peaf.REF.ottman.2010.655">Ottman et al 2010</a>]. On the other hand, identification of the genetic basis of ADEAF enables informed <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> and benefits individuals interested in knowing the cause of their epilepsy.</p><p>The utility of presymptomatic testing is limited because:</p><ul><li class="half_rhythm"><div>Approximately one third of those with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will remain unaffected due to reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>;</div></li><li class="half_rhythm"><div>Seizures are treatable in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals;</div></li><li class="half_rhythm"><div>No methods have been identified to prevent the development of seizures in those with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="peaf.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>LGI1</i>, <i>MICAL1</i>, or <i>RELN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="peaf.Resources"><h2 id="_peaf_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Canadian Epilepsy Alliance</b></div><div>Canada</div><div><b>Phone:</b> 1-866-EPILEPSY (1-866-374-5377)</div><div><a href="http://epilepsymatters.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsymatters.com</a></div></li><li class="half_rhythm"><div><b>Citizens United for Research in Epilepsy (CURE)</b></div><div><a href="http://www.cureepilepsy.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cureepilepsy.org</a></div></li><li class="half_rhythm"><div><b>Epilepsy Canada</b></div><div>Canada</div><div><b>Phone:</b> 877-734-0873</div><div><b>Email:</b> epilepsy@epilepsy.ca</div><div><a href="http://www.epilepsy.ca/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.ca</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li></ul></div><div id="peaf.Molecular_Genetics"><h2 id="_peaf_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="peaf.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Autosomal Dominant Epilepsy with Auditory Features: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1537/table/peaf.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__peaf.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_peaf.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_peaf.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_peaf.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_peaf.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_peaf.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_peaf.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_peaf.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9211" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LGI1</i></a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9211" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q23<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O95970" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Leucine-rich glioma-inactivated protein 1</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/LGI1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LGI1 database</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LGI1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LGI1</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LGI1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LGI1</a></td></tr><tr><td headers="hd_b_peaf.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/64780" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MICAL1</i></a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=64780" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6q21</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8TDZ2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">[F-actin]-monooxygenase MICAL1</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_peaf.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MICAL1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MICAL1</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MICAL1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MICAL1</a></td></tr><tr><td headers="hd_b_peaf.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5649" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RELN</i></a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5649" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q22<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P78509" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Reelin</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/RELN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RELN database</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RELN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RELN</a></td><td headers="hd_b_peaf.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RELN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RELN</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="peaf.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="peaf.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Autosomal Dominant Epilepsy with Auditory Features (<a href="/omim/600512,600514,604619,607129,616436" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1537/table/peaf.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__peaf.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600512" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600512</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600514" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600514</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">REELIN; RELN</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604619" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604619</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 1; LGI1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607129" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607129</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 1; MICAL1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616436" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616436</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7</td></tr></tbody></table></div></div><div id="peaf.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>The proteins reelin and Lgi1 colocalize in a subset of rat brain neurons, supporting a common molecular pathway underlying ADEAF [<a class="bk_pop" href="#peaf.REF.dazzo.2015a.992">Dazzo et al 2015a</a>]. Reelin serves a dual purpose in mammalian brain with critical roles both during embryonic development [<a class="bk_pop" href="#peaf.REF.darcangelo.1995.719">D'Arcangelo et al 1995</a>, <a class="bk_pop" href="#peaf.REF.lambert_de_rouvroit.1998.1">Lambert de Rouvroit &#x00026; Goffinet 1998</a>] and postnatally [<a class="bk_pop" href="#peaf.REF.niu.2004.71">Niu et al 2004</a>, <a class="bk_pop" href="#peaf.REF.beffert.2005.567">Beffert et al 2005</a>]. Work on conditional knockout mice suggests that Lgi1, like reelin, could serve different functions during brain development and in adulthood [<a class="bk_pop" href="#peaf.REF.boillot.2014.2984">Boillot et al 2014</a>]. Thus, a functional interplay between the two proteins may be necessary for proper regulation of various neuronal processes during development and in adult life.</p><p>The protein MICAL1 has an enzymatic oxidoreductase activity that induces disassembly of actin filaments, thereby regulating the organization of the actin cytoskeleton in developing and adult neurons and in other cell types. Dysregulation of the actin cytoskeleton dynamics in neurons is a likely mechanism underlying <i>MICAL1</i>-related ADEAF [<a class="bk_pop" href="#peaf.REF.dazzo.2018.483">Dazzo et al 2018</a>].</p><div id="peaf.LGI1"><h4><i>LGI1</i></h4><p><b>Gene structure.</b> The longest <i>LGI1</i> transcript variant (<a href="/nuccore/171846229" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005097.2</a>) has eight exons. <i>LGI1</i> is a member of a subfamily of leucine-rich repeat (LRR)-encoding genes, denoted <i>LGI1</i>, <i>LGI2</i>, <i>LGI3</i>, and <i>LGI4</i> [<a class="bk_pop" href="#peaf.REF.gu.2002b.71">Gu et al 2002b</a>]. See <a href="/books/NBK1537/#peaf.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Pathogenic variants have been found throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>; they were found to cluster in the LRR <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (exons 3-5) [<a class="bk_pop" href="#peaf.REF.ho.2012.563">Ho et al 2012</a>].</p><p>Of the reported pathogenic variants, two thirds are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and one third are frameshift variants that predict premature translation termination leading to unstable <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> or truncated protein. Three <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> pathogenic variants have been reported, each predicting protein truncation [<a class="bk_pop" href="#peaf.REF.kalachikov.2002.335">Kalachikov et al 2002</a>, <a class="bk_pop" href="#peaf.REF.kobayashi.2003.1546">Kobayashi et al 2003</a>, <a class="bk_pop" href="#peaf.REF.chabrol.2007.217">Chabrol et al 2007</a>]. Almost all of the identified pathogenic variants have been unique to an individual family. The exceptions:</p><ul><li class="half_rhythm"><div>p.Cys46Arg, identified in one Norwegian and one Italian family without known shared antecedents [<a class="bk_pop" href="#peaf.REF.gu.2002a.364">Gu et al 2002a</a>, <a class="bk_pop" href="#peaf.REF.pizzuti.2003.396">Pizzuti et al 2003</a>, <a class="bk_pop" href="#peaf.REF.pizzuti.2003.396_1">Pizzuti &#x00026; Giallonardo 2003</a>]</div></li><li class="half_rhythm"><div>p.Ala253ValfsTer32, identified in two Spanish families from the same region [<a class="bk_pop" href="#peaf.REF.moranteredolat.2002.1119">Morante-Redolat et al 2002</a>, <a class="bk_pop" href="#peaf.REF.michelucci.2003.1289">Michelucci et al 2003</a>]</div></li><li class="half_rhythm"><div>p.Ser473Leu, identified in one Australian and one Japanese family [<a class="bk_pop" href="#peaf.REF.berkovic.2004a.1115">Berkovic et al 2004a</a>, <a class="bk_pop" href="#peaf.REF.kawamata.2010.690">Kawamata et al 2010</a>]</div></li><li class="half_rhythm"><div>p.Arg474Ter, identified in a Basque family and in a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case from Italy, as a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#peaf.REF.moranteredolat.2002.1119">Morante-Redolat et al 2002</a>, <a class="bk_pop" href="#peaf.REF.bisulli.2004b.455">Bisulli et al 2004b</a>]</div></li></ul><p>In addition, two of the reported pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, c.124T&#x0003e;C and c.124T&#x0003e;G, changed the same nucleotide [<a class="bk_pop" href="#peaf.REF.berkovic.2004a.1115">Berkovic et al 2004a</a>, <a class="bk_pop" href="#peaf.REF.ottman.2004.1120">Ottman et al 2004</a>].</p><p>Deletions encompassing one or more exons of <i>LGI1</i> were identified in families with ADEAF in which <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> sequencing revealed no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#peaf.REF.fanciulli.2012.1299">Fanciulli et al 2012</a>, <a class="bk_pop" href="#peaf.REF.dazzo.2015b.132">Dazzo et al 2015b</a>].</p><div id="peaf.T.lgi1_pathogenic_variants_discusse" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>LGI1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1537/table/peaf.T.lgi1_pathogenic_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__peaf.T.lgi1_pathogenic_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.124T&#x0003e;C</td><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys42Arg</td><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/171846229" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005097<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/4826816" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005088<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.124T&#x0003e;G</td><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys42Gly</td></tr><tr><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.136T&#x0003e;C</td><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys46Arg</td></tr><tr><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.758delC</td><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala253ValfsTer32</td></tr><tr><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1418C&#x0003e;T</td><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser473Leu</td></tr><tr><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1420C&#x0003e;T</td><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg474Ter</td></tr><tr><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion of ~81 kb&#x000a0;<sup>1</sup></td><td headers="hd_h_peaf.T.lgi1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="peaf.TF.3.1"><p class="no_margin">Deletes exons 1-4 and maps between <a href="/snp/?term=rs11187602" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rs11187602</a> and <a href="/snp/?term=rs7099034" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rs7099034</a> [<a class="bk_pop" href="#peaf.REF.fanciulli.2012.1299">Fanciulli et al 2012</a>]</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The longest transcript <a href="/nuccore/171846229" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005097.2</a> is predicted to encode the longest isoform, the 557-amino-acid leucine-rich glioma-inactivated protein 1 (Lgi1) (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_005088.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005088.1</a>) [<a class="bk_pop" href="#peaf.REF.nobile.2009.530">Nobile at al 2009</a>]. See <a href="#peaf.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</a>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The function of the normal gene product Lgi1 and the mechanism by which alterations in the protein cause epilepsy remain poorly understood; multiple lines of evidence have been investigated.</p><p>Interestingly, there are two protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>, with different expression patterns in human brain [<a class="bk_pop" href="#peaf.REF.furlan.2006.985">Furlan et al 2006</a>]. The long isoform (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_005088.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005088.1</a>) is secreted [<a class="bk_pop" href="#peaf.REF.sirerolpiquer.2006.3436">Sirerol-Piquer et al 2006</a>]. Most pathogenic variants are defective for secretion, whereas a few pathogenic variants allow protein secretion but reduce the binding ability of the Lgi1 long form to its neuronal receptors ADAM22 and ADAM23 [<a class="bk_pop" href="#peaf.REF.sirerolpiquer.2006.3436">Sirerol-Piquer et al 2006</a>, <a class="bk_pop" href="#peaf.REF.dazzo.2016.e1006376">Dazzo et al 2016</a>].</p><p>One study suggested that Lgi1 may influence the risk for epilepsy through a glutamatergic mechanism: through its interaction with ADAM22, Lgi1 controls the synaptic content of AMPA (&#x003b1;-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors, thereby modulating synaptic transmission as well as regulating the maturation of excitatory synapses [<a class="bk_pop" href="#peaf.REF.lovero.2015.e4129">Lovero et al 2015</a>].</p><p>Studies in transgenic mice showed that overexpression of an <i>Lgi1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, homologous to one known to cause ADEAF in humans, causes epilepsy by impairing the postnatal development of glutamatergic circuits in the hippocampus [<a class="bk_pop" href="#peaf.REF.zhou.2009.1208">Zhou et al 2009</a>].</p><p><b>Cancer and benign tumors.</b> Cancerous tissues obtained from normal individuals show that <i>LGI1</i> expression is absent or significantly downregulated in many high-grade but not low-grade gliomas, suggesting a role for <i>LGI1</i> in glial tumor progression [<a class="bk_pop" href="#peaf.REF.chernova.1998.2873">Chernova et al 1998</a>, <a class="bk_pop" href="#peaf.REF.somerville.2000.622">Somerville et al 2000</a>], although no excess of brain tumors or other malignancies has been found in families with ADEAF.</p></div><div id="peaf.MICAL1"><h4><i>MICAL1</i></h4><p><b>Gene structure.</b> The main <i>MICAL1</i> transcript has 25 exons (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_022765.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_022765.4</a>). <i>MICAL1</i> is a member of a family of genes that includes two more human genes: <i>MICAL2</i> and <i>MICAL3</i>. See <a href="/books/NBK1537/#peaf.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Two pathogenic variants have been identified in two families with ADEAF [<a class="bk_pop" href="#peaf.REF.dazzo.2018.483">Dazzo et al 2018</a>]. A <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant, p.Gly150Ser, was found in the enzymatically active oxidoreductase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, and a two-<a class="def" href="/books/n/gene/glossary/def-item/base-pair/">base pair</a> frameshift <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, p.Ala1065fs, in the C-terminal domain, resulting in truncation of the terminal portion of the protein.</p><div id="peaf.T.mical1_pathogenic_variants_discus" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>MICAL1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1537/table/peaf.T.mical1_pathogenic_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__peaf.T.mical1_pathogenic_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_peaf.T.mical1_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_peaf.T.mical1_pathogenic_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_peaf.T.mical1_pathogenic_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_peaf.T.mical1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.448G&#x0003e;A</td><td headers="hd_h_peaf.T.mical1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly150Ser</td><td headers="hd_h_peaf.T.mical1_pathogenic_variants_discus_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_022765.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_022765<wbr style="display:inline-block"></wbr>​.4</a></td></tr><tr><td headers="hd_h_peaf.T.mical1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3189_3190del</td><td headers="hd_h_peaf.T.mical1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala1065fs</td><td headers="hd_h_peaf.T.mical1_pathogenic_variants_discus_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/protein/NP_073602.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_073602<wbr style="display:inline-block"></wbr>​.3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>MICAL1</i> encodes [F-actin]-monooxygenase MICAL1, a protein of 1,067 amino acids (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_073602.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_073602.3</a>) that contains an enzymatically active oxidoreductase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and three other domains that mediate protein-protein interactions. For a review see <a class="bk_pop" href="#peaf.REF.vanoni.2017.118">Vanoni [2017]</a>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Both pathogenic variants were shown to significantly increase the oxidoreductase activity of MICAL1 and induce cell contraction in cultured cells, which likely resulted from deregulation of actin cytoskeleton dynamics. MICAL1 oxidoreductase activity is autoinhibited by the C-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, so that the wild type protein is nearly inactive. A small <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> like p.Ala1065fs that alters the structure of the C-terminal domain reduces its ability to suppress the oxidoreductase activity, which is therefore increased (gain of function). The p.Gly150Ser variant affects a highly conserved glycine residue, the substitution of which with a polar serine may result in a local perturbation of domain conformation that partially releases inhibition by the C-terminal domain.</p></div><div id="peaf.RELN"><h4><i>RELN</i></h4><p><b>Gene structure.</b> The longest <i>RELN</i> transcript has 65 exons and is primarily expressed in the brain [<a class="bk_pop" href="#peaf.REF.dazzo.2015a.992">Dazzo et al 2015a</a>]. Two transcript variants encoding distinct <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> have been identified for this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Other transcript variants have been described but their full length nature has not been determined. See <a href="/books/NBK1537/#peaf.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of gene and protein information.</p><p><b>Pathogenic variants.</b> Seven pathogenic variants have been identified in seven Italian families with ADEAF [<a class="bk_pop" href="#peaf.REF.dazzo.2015a.992">Dazzo et al 2015a</a>]. All were <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that affected structurally important amino acids or likely affected protein folding. Four pathogenic variants &#x02013; p.Asp763Gly, p.His798Asn, p.Gly2783Cys, and p.Glu3176Lys &#x02013; were shown to reduce serum levels of reelin, suggesting a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> effect due to impaired protein secretion [<a class="bk_pop" href="#peaf.REF.dazzo.2015a.992">Dazzo et al 2015a</a>].</p><div id="peaf.T.reln_pathogenic_variants_discusse" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>RELN</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1537/table/peaf.T.reln_pathogenic_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__peaf.T.reln_pathogenic_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2015C&#x0003e;T</td><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro672Leu</td><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005045.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005045<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_005036.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005036<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2168A&#x0003e;G</td><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr723Cys</td></tr><tr><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2288A&#x0003e;G</td><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp763Gly</td></tr><tr><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2392C&#x0003e;A</td><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His798Asn</td></tr><tr><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2531C&#x0003e;T</td><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro844Leu</td></tr><tr><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.8347G&#x0003e;T</td><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly2783Cys</td></tr><tr><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.9526G&#x0003e;A</td><td headers="hd_h_peaf.T.reln_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu3176Lys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>RELN</i> encodes reelin, a very large secreted protein of 3,460 amino acids. See <a href="#peaf.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</a> and <a class="bk_pop" href="#peaf.REF.darcangelo.2014">D'Arcangelo [2014]</a> for a review.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>RELN</i> were associated with decreased serum levels of reelin, suggesting an inhibitory effect on protein secretion [<a class="bk_pop" href="#peaf.REF.dazzo.2015a.992">Dazzo et al 2015a</a>]. Reduced levels of serum reelin are observed in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>reeler</i> mice [<a class="bk_pop" href="#peaf.REF.smalheiser.2000.1281">Smalheiser et al 2000</a>], which have apparently normal brains but display functional and molecular defects at the synapse [<a class="bk_pop" href="#peaf.REF.ventruti.2011.32">Ventruti et al 2011</a>]. Similar synaptic defects may also be associated with the heterozygous pathogenic variants in <i>RELN</i> in ADEAF, eventually giving rise to epilepsy.</p><p>In humans, <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <i>RELN</i> pathogenic variants cause <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> lissencephaly with cerebellar hypoplasia (LCH) (OMIM <a href="http://omim.org/entry/257320" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">257320</a>) [<a class="bk_pop" href="#peaf.REF.hong.2000.93">Hong et al 2000</a>]. In three small <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families with LCH reported, clinically normal heterozygotes (carriers of one <i>RELN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>) exhibited reduced serum reelin [<a class="bk_pop" href="#peaf.REF.hong.2000.93">Hong et al 2000</a>, <a class="bk_pop" href="#peaf.REF.zaki.2007.939">Zaki et al 2007</a>]. The apparently normal <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is consistent with the relatively low <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <i>RELN</i> pathogenic variants in families with ADEAF. Thus, as in other genetic epilepsy syndromes, <i>RELN</i>-related disorders may be genetically and clinically heterogeneous, with pathogenic variants resulting in ADEAF in heterozygotes and the more severe LCH in homozygotes.</p></div></div></div><div id="peaf.References"><h2 id="_peaf_References_">References</h2><div id="peaf.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.andermann.2005.61">Andermann F, Kobayashi E, Andermann E. Genetic focal epilepsies: state of the art and paths to the future. <span><span class="ref-journal">Epilepsia. </span>2005;<span class="ref-vol">46</span> Suppl 10:61–7.</span> [<a href="/pubmed/16359475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16359475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.beffert.2005.567">Beffert U, Weeber EJ, Durudas A, Qiu S, Masiulis I, Sweatt JD, Li WP, Adelmann G, Frotscher M, Hammer RE, Herz J. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. <span><span class="ref-journal">Neuron. </span>2005;<span class="ref-vol">47</span>:567–79.</span> [<a href="/pubmed/16102539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16102539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.berkovic.2004a.1115">Berkovic SF, Izzillo P, McMahon JM, Harkin LA, McIntosh AM, Phillips HA, Briellmann RS, Wallace RH, Mazarib A, Neufeld MY, Korczyn AD, Scheffer IE, Mulley JC. LGI1 mutations in temporal lobe epilepsies. <span><span class="ref-journal">Neurology. </span>2004a;<span class="ref-vol">62</span>:1115–9.</span> [<a href="/pubmed/15079010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15079010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.berkovic.2004b.1054">Berkovic SF, Serratosa JM, Phillips HA, Xiong L, Andermann E, D&#x000ed;az-Otero F, G&#x000f3;mez-Garre P, Mart&#x000ed;n M, Fern&#x000e1;ndez-Bullido Y, Andermann F, Lopes-Cendes I, Dubeau F, Desbiens R, Scheffer IE, Wallace RH, Mulley JC, Pandolfo M. Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. <span><span class="ref-journal">Epilepsia. </span>2004b;<span class="ref-vol">45</span>:1054–60.</span> [<a href="/pubmed/15329069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15329069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.bisulli.2014.841">Bisulli F, Naldi I, Baldassari S, Magini P, Licchetta L, Castegnaro G, Fabbri M, Stipa C, Ferrari S, Seri M, Goncalves Silva GE, Tinuper P, Pippucci T. Autosomal dominant partial epilepsy with auditory features: a new locus on chromosome 19q13.11-q13.31. <span><span class="ref-journal">Epilepsia. </span>2014;<span class="ref-vol">55</span>:841–8.</span> [<a href="/pubmed/24579982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24579982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.bisulli.2004a.1343">Bisulli F, Tinuper P, Avoni P, Striano P, Striano S, d'Orsi G, Vignatelli L, Bagattin A, Scudellaro E, Florindo I, Nobile C, Tassinari CA, Baruzzi A, Michelucci R. Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. <span><span class="ref-journal">Brain. </span>2004a;<span class="ref-vol">127</span>:1343–52.</span> [<a href="/pubmed/15090473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15090473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.bisulli.2004b.455">Bisulli F, Tinuper P, Scudellaro E, Naldi I, Bagattin A, Avoni P, Michelucci R, Nobile C. A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. <span><span class="ref-journal">Ann Neurol. </span>2004b;<span class="ref-vol">56</span>:455–6.</span> [<a href="/pubmed/15349881" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15349881</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.boillot.2014.2984">Boillot M, Huneau C, Marsan E, Lehongre K, Navarro V, Ishida S, Dufresnois B, Ozkaynak E, Garrigue J, Miles R, Martin B, Leguern E, Anderson MP, Baulac S. Glutamatergic neuron-targeted loss of LGI1 epilepsy gene results in seizures. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:2984–96.</span> [<a href="/pmc/articles/PMC4208469/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4208469</span></a>] [<a href="/pubmed/25234641" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25234641</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.brodtkorb.2002.228">Brodtkorb E, Gu W, Nakken KO, Fischer C, Steinlein OK. Familial temporal lobe epilepsy with aphasic seizures and linkage to chromosome 10q22-q24. <span><span class="ref-journal">Epilepsia. </span>2002;<span class="ref-vol">43</span>:228–35.</span> [<a href="/pubmed/11906506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11906506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.brodtkorb.2005a.963">Brodtkorb E, Michler RP, Gu W, Steinlein OK. Speech-induced aphasic seizures in epilepsy caused by LGI1 mutation. <span><span class="ref-journal">Epilepsia. </span>2005a;<span class="ref-vol">46</span>:963–6.</span> [<a href="/pubmed/15946341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15946341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.brodtkorb.2005b.1692">Brodtkorb E, Steinlein OK, Sand T. Asymmetry of long-latency auditory evoked potentials in LGI1-related autosomal dominant lateral temporal lobe epilepsy. <span><span class="ref-journal">Epilepsia. </span>2005b;<span class="ref-vol">46</span>:1692–4.</span> [<a href="/pubmed/16190946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16190946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.callenbach.2003.1298">Callenbach PM, van den Maagdenberg AM, Hottenga JJ, van den Boogerd EH, de Coo RF, Lindhout D, Frants RR, Sandkuijl LA, Brouwer OF. Familial partial epilepsy with variable foci in a Dutch family: clinical characteristics and confirmation of linkage to chromosome 22q. <span><span class="ref-journal">Epilepsia. </span>2003;<span class="ref-vol">44</span>:1298–305.</span> [<a href="/pubmed/14510823" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14510823</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.chabrol.2007.217">Chabrol E, Popescu C, Gourfinkel-An I, Trouillard O, Depienne C, Senechal K, Baulac M, LeGuern E, Baulac S. Two novel epilepsy-linked mutations leading to a loss of function of LGI1. <span><span class="ref-journal">Arch Neurol. </span>2007;<span class="ref-vol">64</span>:217–22.</span> [<a href="/pubmed/17296837" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17296837</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.chernova.1998.2873">Chernova OB, Somerville RP, Cowell JK. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. <span><span class="ref-journal">Oncogene. </span>1998;<span class="ref-vol">17</span>:2873–81.</span> [<a href="/pubmed/9879993" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9879993</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.darcangelo.2014">D'Arcangelo G. Reelin in the years: controlling neuronal migration and maturation in the mammalian brain. Advances in Neuroscience. 2014. Available <a href="https://www.hindawi.com/journals/aneu/2014/597395/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>.</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.darcangelo.1995.719">D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. <span><span class="ref-journal">Nature. </span>1995;<span class="ref-vol">374</span>:719–23.</span> [<a href="/pubmed/7715726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7715726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.dazzo.2015a.992">Dazzo E, Fanciulli M, Serioli E, Minervini G, Pulitano P, Binelli S, Di Bonaventura C, Luisi C, Pasini E, Striano S, Striano P, Coppola G, Chiavegato A, Radovic S, Spadotto A, Uzzau S, La Neve A, Giallonardo AT, Mecarelli O, Tosatto SC, Ottman R, Michelucci R, Nobile C. Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy. <span><span class="ref-journal">Am J Hum Genet. </span>2015a;<span class="ref-vol">96</span>:992–1000.</span> [<a href="/pmc/articles/PMC4457960/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4457960</span></a>] [<a href="/pubmed/26046367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26046367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.dazzo.2016.e1006376">Dazzo E, Leonardi E, Belluzzi E, Malacrida S, Vitiello L, Greggio E, Tosatto SC, Nobile C. Secretion-positive LGI1 mutations linked to lateral temporal epilepsy impair binding to ADAM22 and ADAM23 receptors. <span><span class="ref-journal">PLoS Genet. </span>2016;<span class="ref-vol">12</span>:e1006376.</span> [<a href="/pmc/articles/PMC5070869/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5070869</span></a>] [<a href="/pubmed/27760137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27760137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.dazzo.2018.483">Dazzo E, Rehberg K, Michelucci R, Passarelli D, Boniver C, Vianello Dri V, Striano P, Striano S, Pasterkamp RJ, Nobile C. Mutations in MICAL-1 cause autosomal-dominant lateral temporal epilepsy. <span><span class="ref-journal">Ann Neurol. </span>2018;<span class="ref-vol">83</span>:483–93.</span> [<a href="/pubmed/29394500" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29394500</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.dazzo.2015b.132">Dazzo E, Santulli L, Posar A, Fattouch J, Conti S, Loden-van Straaten M, Mijalkovic J, De Bortoli M, Rosa M, Millino C, Pacchioni B, Di Bonaventura C, Giallonardo AT, Striano S, Striano P, Parmeggiani A, Nobile C. Autosomal dominant lateral temporal epilepsy (ADLTE): novel structural and single-nucleotide LGI1 mutations in families with predominant visual auras. <span><span class="ref-journal">Epilepsy Res. </span>2015b;<span class="ref-vol">110</span>:132–8.</span> [<a href="/pubmed/25616465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25616465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.deprez.2007.1995">Deprez L, Peeters K, Van Paesschen W, Claeys KG, Claes LR, Suls A, Audenaert D, Van Dyck T, Goossens D, Del-Favero J, De Jonghe P. Familial occipitotemporal lobe epilepsy and migraine with visual aura &#x02013; linkage to chromosome 9q. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">68</span>:1995–2002.</span> [<a href="/pubmed/17460155" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17460155</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.di_bonaventura.2009.2481">Di Bonaventura C, Carni M, Diani E, Fattouch J, Vaudano EA, Egeo G, Pantano P, Maraviglia B, Bozzao L, Manfredi M, Prencipe M, Giallonardo TA, Nobile C. Drug resistant ADLTE and recurrent partial status epilepticus with dysphasic features in a family with a novel LGI1 mutation: electroclinical, genetic, and EEG/fMRI findings. <span><span class="ref-journal">Epilepsia. </span>2009;<span class="ref-vol">50</span>:2481–6.</span> [<a href="/pubmed/19552651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19552651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.dibbens.2013.546">Dibbens LM, de Vries B, Donatello S, Heron SE, Hodgson BL, Chintawar S, Crompton DE, Hughes JN, Bellows ST, Klein KM, Callenbach PM, Corbett MA, Gardner AE, Kivity S, Iona X, Regan BM, Weller CM, Crimmins D, O'Brien TJ, Guerrero-Lopez R, Mulley JC, Dubeau F, Licchetta L, Bisulli F, Cossette P, Thomas PQ, Gecz J, Serratosa J, Brouwer OF, Andermann F, Andermann E, van den Maagdenberg AM, Pandolfo M, Berkovic SF, Scheffer IE. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:546–51.</span> [<a href="/pubmed/23542697" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23542697</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.fanciulli.2014.1651">Fanciulli M, Pasini E, Malacrida S, Striano P, Striano S, Michelucci R, Ottman R, Nobile C. Copy number variations and susceptibility to lateral temporal epilepsy: a study of 21 pedigrees. <span><span class="ref-journal">Epilepsia. </span>2014;<span class="ref-vol">55</span>:1651–8.</span> [<a href="/pubmed/25243798" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25243798</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.fanciulli.2012.1299">Fanciulli M, Santulli L, Errichiello L, Barozzi C, Tomasi L, Rigon L, Cubeddu T, de Falco A, Rampazzo A, Michelucci R, Uzzau S, Striano S, de Falco FA, Striano P, Nobile C. LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:1299–303.</span> [<a href="/pmc/articles/PMC3335451/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3335451</span></a>] [<a href="/pubmed/22496201" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22496201</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.fertig.2003.1687">Fertig E, Lincoln A, Martinuzzi A, Mattson RH, Hisama FM. Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:1687–90.</span> [<a href="/pubmed/12771268" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12771268</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.flex.2005.62">Flex E, Pizzuti A, Di Bonaventura C, Douzgou S, Egeo G, Fattouch J, Manfredi M, Dallapiccola B, Giallonardo AT. LGI1 gene mutation screening in sporadic partial epilepsy with auditory features. <span><span class="ref-journal">J Neurol. </span>2005;<span class="ref-vol">252</span>:62–6.</span> [<a href="/pubmed/15654555" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15654555</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.furlan.2006.985">Furlan S, Roncaroli F, Forner F, Vitiello L, Calabria E, Piquer-Sirerol S, Valle G, Perez-Tur J, Michelucci R, Nobile C. The LGI1/epitempin gene encodes two protein isoforms differentially expressed in human brain. <span><span class="ref-journal">J Neurochem. </span>2006;<span class="ref-vol">98</span>:985–91.</span> [<a href="/pubmed/16787412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16787412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.gu.2002a.364">Gu W, Brodtkorb E, Steinlein OK. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. <span><span class="ref-journal">Ann Neurol. </span>2002a;<span class="ref-vol">52</span>:364–7.</span> [<a href="/pubmed/12205652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12205652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.gu.2002b.71">Gu W, Wevers A, Schr&#x000f6;der H, Grzeschik KH, Derst C, Brodtkorb E, de Vos R, Steinlein OK. The LGI1 gene involved in lateral temporal lobe epilepsy belongs to a new subfamily of leucine-rich repeat proteins. <span><span class="ref-journal">FEBS Lett. </span>2002b;<span class="ref-vol">519</span>:71–6.</span> [<a href="/pubmed/12023020" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12023020</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.hedera.2004.218">Hedera P, Abou-Khalil B, Crunk AE, Taylor KA, Haines JL, Sutcliffe JS. Autosomal dominant lateral temporal epilepsy: two families with novel mutations in the LGI1 gene. <span><span class="ref-journal">Epilepsia. </span>2004;<span class="ref-vol">45</span>:218–22.</span> [<a href="/pubmed/15009222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15009222</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.heiman.2010.1685">Heiman GA, Kamberakis K, Gill R, Kalachikov S, Pedley TA, Hauser WA, Ottman R. Evaluation of depression risk in LGI1 mutation carriers. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span>:1685–90.</span> [<a href="/pmc/articles/PMC2939248/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2939248</span></a>] [<a href="/pubmed/20659151" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20659151</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.ho.2012.563">Ho YY, Ionita-Laza I, Ottman R. Domain-dependent clustering and genotype-phenotype analysis of LGI1 mutations in ADPEAF. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:563–8.</span> [<a href="/pmc/articles/PMC3280014/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3280014</span></a>] [<a href="/pubmed/22323750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22323750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.hong.2000.93">Hong SE, Shugart YY, Huang DT, Shahwan SA, Grant PE, Hourihane JO, Martin ND, Walsh CA. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">26</span>:93–6.</span> [<a href="/pubmed/10973257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10973257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.kalachikov.2002.335">Kalachikov S, Evgrafov O, Ross B, Winawer M, Barker-Cummings C, Martinelli Boneschi F, Choi C, Morozov P, Das K, Teplitskaya E, Yu A, Cayanis E, Penchaszadeh G, Kottmann AH, Pedley TA, Hauser WA, Ottman R, Gilliam TC. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">30</span>:335–41.</span> [<a href="/pmc/articles/PMC2606053/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2606053</span></a>] [<a href="/pubmed/11810107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11810107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.kanemoto.2000.1036">Kanemoto K, Kawasaki J. Familial aphasic episodes: another variant of partial epilepsy with simple inheritance? <span><span class="ref-journal">Epilepsia. </span>2000;<span class="ref-vol">41</span>:1036–8.</span> [<a href="/pubmed/10961632" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10961632</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.kawamata.2010.690">Kawamata J, Ikeda A, Fujita Y, Usui K, Shimohama S, Takahashi R. Mutations in LGI1 gene in Japanese families with autosomal dominant lateral temporal lobe epilepsy: the first report from Asian families. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span>:690–3.</span> [<a href="/pubmed/19780791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19780791</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.kesim.2016.73">Kesim YF, Uzun GA, Yucesan E, Tuncer FN, Ozdemir O, Bebek N, Ozbek U, Iseri SA, Baykan B. Screening LGI1 in a cohort of 26 lateral temporal lobe epilepsy patients with auditory aura from Turkey detects a novel de novo mutation. <span><span class="ref-journal">Epilepsy Res. </span>2016;<span class="ref-vol">120</span>:73–8.</span> [<a href="/pubmed/26773249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26773249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.kobayashi.2003.1546">Kobayashi E, Santos NF, Torres FR, Secolin R, Sardinha LA, Lopez-Cendes I, Cendes F. Magnetic resonance imaging abnormalities in familial temporal lobe epilepsy with auditory auras. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:1546–51.</span> [<a href="/pubmed/14623726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14623726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.lambert_de_rouvroit.1998.1">Lambert de Rouvroit C, Goffinet AM. The reeler mouse as a model of brain development. <span><span class="ref-journal">Adv Anat Embryol Cell Biol. </span>1998;<span class="ref-vol">150</span>:1–106.</span> [<a href="/pubmed/9816727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9816727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.lovero.2015.e4129">Lovero KL, Fukata Y, Granger AJ, Fukata M, Nicoll RA. The LGI1-ADAM22 protein complex directs synapse maturation through regulation of PSD-95 function. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2015;<span class="ref-vol">112</span>:E4129–37.</span> [<a href="/pmc/articles/PMC4522810/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4522810</span></a>] [<a href="/pubmed/26178195" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26178195</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.magini.2014.972">Magini P, Bisulli F, Baldassari S, Stipa C, Naldi I, Licchetta L, Menghi V, Tinuper P, Seri M, Pippucci T. LGI1 microdeletions are not a frequent cause of partial epilepsy with auditory features (PEAF). <span><span class="ref-journal">Epilepsy Res. </span>2014;<span class="ref-vol">108</span>:972–7.</span> [<a href="/pubmed/24721199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24721199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.manna.2014.597">Manna I, Mumoli L, Labate A, Citrigno L, Ferlazzo E, Aguglia U, Quattrone A, Gambardella A. Autosomal dominant lateral temporal epilepsy (ADLTE): absence of chromosomal rearrangements in LGI1 gene. <span><span class="ref-journal">Epilepsy Res. </span>2014;<span class="ref-vol">108</span>:597–9.</span> [<a href="/pubmed/24315022" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24315022</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.michelucci.2004.280">Michelucci R, Gardella E, de Haan GJ, Bisulli F, Zaniboni A, Cantalupo G, Alberto Tassinari C, Tinuper P, Nobile C, Nichelli P, Kasteleijn-Nolst Trenit&#x000e9; DG. Telephone-induced seizures: a new type of reflex epilepsy. <span><span class="ref-journal">Epilepsia. </span>2004;<span class="ref-vol">45</span>:280–3.</span> [<a href="/pubmed/15009231" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15009231</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.michelucci.2007.2150">Michelucci R, Mecarelli O, Bovo G, Bisulli F, Testoni S, Striano P, Striano S, Tinuper P, Nobile C. A de novo LGI1 mutation causing idiopathic partial epilepsy with telephone-induced seizures. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">68</span>:2150–1.</span> [<a href="/pubmed/17562837" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17562837</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.michelucci.2013.1288">Michelucci R, Pasini E, Malacrida S, Striano P, Bonaventura CD, Pulitano P, Bisulli F, Egeo G, Santulli L, Sofia V, Gambardella A, Elia M, de Falco A, Neve A, Banfi P, Coppola G, Avoni P, Binelli S, Boniver C, Pisano T, Marchini M, Dazzo E, Fanciulli M, Bartolini Y, Riguzzi P, Volpi L, de Falco FA, Giallonardo AT, Mecarelli O, Striano S, Tinuper P, Nobile C. Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations. <span><span class="ref-journal">Epilepsia. </span>2013;<span class="ref-vol">54</span>:1288–97.</span> [<a href="/pubmed/23621105" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23621105</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.michelucci.2009.52">Michelucci R, Pasini E, Nobile C. Lateral temporal lobe epilepsies: clinical and genetic features. <span><span class="ref-journal">Epilepsia. </span>2009;<span class="ref-vol">50</span> Suppl 5:52–4.</span> [<a href="/pubmed/19469848" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19469848</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.michelucci.2003.1289">Michelucci R, Poza JJ, Sofia V, de Feo MR, Binelli S, Bisulli F, Scudellaro E, Simionati B, Zimbello R, D'Orsi G, Passarelli D, Avoni P, Avanzini G, Tinuper P, Biondi R, Valle G, Mautner VF, Stephani U, Tassinari CA, Moschonas NK, Siebert R, Lopez de Munain A, Perez-Tur J, Nobile C. Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families. <span><span class="ref-journal">Epilepsia. </span>2003;<span class="ref-vol">44</span>:1289–97.</span> [<a href="/pubmed/14510822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14510822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.michelucci.2017.103">Michelucci R, Pulitano P, Di Bonaventura C, Binelli S, Luisi C, Pasini E, Striano S, Striano P, Coppola G, La Neve A, Giallonardo AT, Mecarelli O, Serioli E, Dazzo E, Fanciulli M, Nobile C. The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations. <span><span class="ref-journal">Epilepsy Behav. </span>2017;<span class="ref-vol">68</span>:103–7.</span> [<a href="/pmc/articles/PMC5378904/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5378904</span></a>] [<a href="/pubmed/28142128" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28142128</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.moranteredolat.2002.1119">Morante-Redolat JM, Gorostidi-Pagola A, Piquer-Sirerol S, S&#x000e1;enz A, Poza JJ, Gal&#x000e1;n J, Gesk S, Sarafidou T, Mautner VF, Binelli S, Staub E, Hinzmann B, French L, Prud'homme JF, Passarelli D, Scannapieco P, Tassinari CA, Avanzini G, Mart&#x000ed;-Mass&#x000f3; JF, Kluwe L, Deloukas P, Moschonas NK, Michelucci R, Siebert R, Nobile C, P&#x000e9;rez-Tur J, L&#x000f3;pez de Munain A. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. <span><span class="ref-journal">Hum Mol Genet. </span>2002;<span class="ref-vol">11</span>:1119–28.</span> [<a href="/pubmed/11978770" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11978770</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.niu.2004.71">Niu S, Renfro A, Quattrocchi CC, Sheldon M, D'Arcangelo G. Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. <span><span class="ref-journal">Neuron. </span>2004;<span class="ref-vol">41</span>:71–84.</span> [<a href="/pubmed/14715136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14715136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.nobile.2009.530">Nobile C, Michelucci R, Andreazza S, Pasini E, Tosatto SC, Striano P. LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:530–6.</span> [<a href="/pubmed/19191227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19191227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.ottman.2010.655">Ottman R, Hirose S, Jain S, Lerche H, Lopes-Cendes I, Noebels JL, Serratosa J, Zara F, Scheffer IE. Genetic testing in the epilepsies&#x02014;report of the ILAE Genetics Commission. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span>:655–70.</span> [<a href="/pmc/articles/PMC2855784/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2855784</span></a>] [<a href="/pubmed/20100225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20100225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.ottman.1995.56">Ottman R, Risch N, Hauser WA, Pedley TA, Lee JH, Barker-Cummings C, Lustenberger A, Nagle KJ, Lee KS, Scheuer ML, Neystat M, Susser M, Wilhelmsen K. Localization of a gene for partial epilepsy to chromosome 10q. <span><span class="ref-journal">Nat Genet. </span>1995;<span class="ref-vol">10</span>:56–60.</span> [<a href="/pmc/articles/PMC2823475/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2823475</span></a>] [<a href="/pubmed/7647791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7647791</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.ottman.2008.1973">Ottman R, Rosenberger L, Bagic A, Kamberakis K, Ritzl EK, Wohlschlager AM, Shamim S, Sato S, Liew C, Gaillard WD, Wiggs E, Berl MM, Reeves-Tyer P, Baker EH, Butman JA, Theodore WH. Altered language processing in autosomal dominant partial epilepsy with auditory features. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:1973–80.</span> [<a href="/pmc/articles/PMC2654241/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2654241</span></a>] [<a href="/pubmed/19064878" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19064878</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.ottman.2004.1120">Ottman R, Winawer MR, Kalachikov S, Barker-Cummings C, Gilliam TC, Pedley TA, Hauser WA. LGI1 mutations in autosomal dominant partial epilepsy with auditory features. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:1120–6.</span> [<a href="/pmc/articles/PMC1361770/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1361770</span></a>] [<a href="/pubmed/15079011" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15079011</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.picard.2000.1247">Picard F, Baulac S, Kahane P, Hirsch E, Sebastianelli R, Thomas P, Vigevano F, Genton P, Guerrini R, Gericke CA, An I, Rudolf G, Herman A, Brice A, Marescaux C, LeGuern E. Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. <span><span class="ref-journal">Brain. </span>2000;<span class="ref-vol">123</span>:1247–62.</span> [<a href="/pubmed/10825362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10825362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.pisano.2005.118">Pisano T, Marini C, Brovedani P, Brizzolara D, Pruna D, Mei D, Moro F, Cianchetti C, Guerrini R. Abnormal phonologic processing in familial lateral temporal lobe epilepsy due to a new LGI1 mutation. <span><span class="ref-journal">Epilepsia. </span>2005;<span class="ref-vol">46</span>:118–23.</span> [<a href="/pubmed/15660777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15660777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.pizzuti.2003.396">Pizzuti A, Flex E, Di Bonaventura C, Dottorini T, Egeo G, Manfredi M, Dallapiccola B, Giallonardo AT. Epilepsy with auditory features: a LGI1 gene mutation suggests a loss-of-function mechanism. <span><span class="ref-journal">Ann Neurol. </span>2003;<span class="ref-vol">53</span>:396–9.</span> [<a href="/pubmed/12601709" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12601709</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.pizzuti.2003.396_1">Pizzuti A, Giallonardo AT. Epilepsy with auditory features: a LGI1 gene mutation suggests a loss-of-function mechanism. <span><span class="ref-journal">Ann Neurol. </span>2003;<span class="ref-vol">53</span>:396–9.</span> Errata. [<a href="/pubmed/12601709" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12601709</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.poduri.2014.631">Poduri A. DEPDC5 does it all: shared genetics for diverse epilepsy syndromes. <span><span class="ref-journal">Ann Neurol. </span>2014;<span class="ref-vol">75</span>:631–3.</span> [<a href="/pubmed/24753000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24753000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.poza.1999.182">Poza JJ, S&#x000e1;enz A, Mart&#x000ed;nez-Gil A, Cheron N, Cobo AM, Urtasun M, Mart&#x000ed;-Mass&#x000f3; JF, Grid D, Beckmann JS, Prud'homme JF, L&#x000f3;pez de Munain A. Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q. <span><span class="ref-journal">Ann Neurol. </span>1999;<span class="ref-vol">45</span>:182–8.</span> [<a href="/pubmed/9989620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9989620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.rosanoff.2008.567">Rosanoff MJ, Ottman R. Penetrance of LGI1 mutations in autosomal dominant partial epilepsy with auditory features. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:567–71.</span> [<a href="/pmc/articles/PMC2652575/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2652575</span></a>] [<a href="/pubmed/18711109" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18711109</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.sarma.2016.467">Sarma AK, Khandker N, Kurczewski L, Brophy GM. Medical management of epileptic seizures: challenges and solutions. <span><span class="ref-journal">Neuropsychiatr Dis Treat. </span>2016;<span class="ref-vol">12</span>:467–85.</span> [<a href="/pmc/articles/PMC4771397/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4771397</span></a>] [<a href="/pubmed/26966367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26966367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.scheffer.1998.890">Scheffer IE, Phillips HA, O'Brien CE, Saling MM, Wrennall JA, Wallace RH, Mulley JC, Berkovic SF. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. <span><span class="ref-journal">Ann Neurol. </span>1998;<span class="ref-vol">44</span>:890–9.</span> [<a href="/pubmed/9851433" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9851433</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.sirerolpiquer.2006.3436">Sirerol-Piquer MS, Ayerdi-Izquierdo A, Morante-Redolat JM, Herranz-P&#x000e9;rez V, Favell K, Barker PA, P&#x000e9;rez-Tur J. The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. <span><span class="ref-journal">Hum Mol Genet. </span>2006;<span class="ref-vol">15</span>:3436–45.</span> [<a href="/pubmed/17067999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17067999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.smalheiser.2000.1281">Smalheiser NR, Costa E, Guidotti A, Impagnatiello F, Auta J, Lacor P, Kriho V, Pappas GD. Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2000;<span class="ref-vol">97</span>:1281–6.</span> [<a href="/pmc/articles/PMC15597/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC15597</span></a>] [<a href="/pubmed/10655522" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10655522</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.somerville.2000.622">Somerville RP, Chernova O, Liu S, Shoshan Y, Cowell JK. Identification of the promoter, genomic structure, and mouse ortholog of LGI1. <span><span class="ref-journal">Mamm Genome. </span>2000;<span class="ref-vol">11</span>:622–7.</span> [<a href="/pubmed/10920229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10920229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.tessa.2007.1298">Tessa C, Michelucci R, Nobile C, Giannelli M, Della Nave R, Testoni S, Bianucci D, Tinuper P, Bisulli F, Sofia V, De Feo MR, Giallonardo AT, Tassinari CA, Mascalchi M. Structural anomaly of left lateral temporal lobe in epilepsy due to mutated LGI1. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">69</span>:1298–300.</span> [<a href="/pubmed/17875918" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17875918</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.usui.2009.1923">Usui K, Ikeda A, Nagamine T, Matsubayashi J, Matsumoto R, Hiraumi H, Kawamata J, Matsuhashi M, Takahashi R, Fukuyama H. Abnormal auditory cortex with giant N100m signal in patients with autosomal dominant lateral temporal lobe epilepsy. <span><span class="ref-journal">Clin Neurophysiol. </span>2009;<span class="ref-vol">120</span>:1923–6.</span> [<a href="/pubmed/19793676" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19793676</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.vanoni.2017.118">Vanoni MA. Structure-function studies of MICAL, the unusual multidomain flavoenzyme involved in actin cytoskeleton dynamics. <span><span class="ref-journal">Arch Biochem Biophys. </span>2017;<span class="ref-vol">632</span>:118–41.</span> [<a href="/pubmed/28602956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28602956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.ventruti.2011.32">Ventruti A, Kazdoba TM, Niu S, D'Arcangelo G. Reelin deficiency causes specific defects in the molecular composition of the synapses in the adult brain. <span><span class="ref-journal">Neuroscience. </span>2011;<span class="ref-vol">189</span>:32–42.</span> [<a href="/pubmed/21664258" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21664258</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.wang.2006.1081">Wang Y, Ottman R, Rabinowitz D. A method for estimating penetrance from families sampled for linkage analysis. <span><span class="ref-journal">Biometrics. </span>2006;<span class="ref-vol">62</span>:1081–8.</span> [<a href="/pmc/articles/PMC1839037/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1839037</span></a>] [<a href="/pubmed/17156282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17156282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.winawer.2002.60">Winawer MR, Martinelli Boneschi F, Barker-Cummings C, Lee JH, Liu J, Mekios C, Gilliam TC, Pedley TA, Hauser WA, Ottman R. Four new families with autosomal dominant partial epilepsy with auditory features: clinical description and linkage to chromosome 10q24. <span><span class="ref-journal">Epilepsia. </span>2002;<span class="ref-vol">43</span>:60–7.</span> [<a href="/pmc/articles/PMC2707111/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2707111</span></a>] [<a href="/pubmed/11879388" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11879388</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.winawer.2000.2173">Winawer MR, Ottman R, Hauser WA, Pedley TA. Autosomal dominant partial epilepsy with auditory features: defining the phenotype. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">54</span>:2173–6.</span> [<a href="/pmc/articles/PMC2659636/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2659636</span></a>] [<a href="/pubmed/10851389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10851389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.xiong.1999.1698">Xiong L, Labuda M, Li DS, Hudson TJ, Desbiens R, Patry G, Verret S, Langevin P, Mercho S, Seni MH, Scheffer I, Dubeau F, Berkovic SF, Andermann F, Andermann E, Pandolfo M. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">65</span>:1698–710.</span> [<a href="/pmc/articles/PMC1288381/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288381</span></a>] [<a href="/pubmed/10577924" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10577924</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.zaki.2007.939">Zaki M, Shehab M, El-Aleem AA, Abdel-Salam G, Koeller HB, Ilkin Y, Ross ME, Dobyns WB, Gleeson JG. Identification of a novel recessive RELN mutation using a homozygous balanced reciprocal translocation. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:939–44.</span> [<a href="/pubmed/17431900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17431900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="peaf.REF.zhou.2009.1208">Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. <span><span class="ref-journal">Nat Med. </span>2009;<span class="ref-vol">15</span>:1208–14.</span> [<a href="/pmc/articles/PMC2759408/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2759408</span></a>] [<a href="/pubmed/19701204" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19701204</span></a>]</div></li></ul></div></div><div id="peaf.Chapter_Notes"><h2 id="_peaf_Chapter_Notes_">Chapter Notes</h2><div id="peaf.Author_Notes"><h3>Author Notes</h3><p>To volunteer for research, please contact:</p><p>Project Coordinator, Epilepsy Family Study of Columbia University<br />Columbia University <br />Tel: 212-305-9188 <br />Email: <a href="mailto:dev@null" data-email="ude.aibmuloc@ucsfe" class="oemail">ude.aibmuloc@ucsfe</a></p></div><div id="peaf.Author_History"><h3>Author History</h3><p>Roberto Michelucci, MD, PhD (2019-present)<br />Carlo Nobile, PhD (2019-present)<br />Ruth Ottman, PhD; Columbia University (2007-2019)</p></div><div id="peaf.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>10 January 2019 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 August 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>31 January 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>13 July 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 September 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available on a clinical basis; <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available</div></li><li class="half_rhythm"><div>20 April 2007 (me) Review posted live</div></li><li class="half_rhythm"><div>1 February 2007 (ro) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1537</span><span class="label">PMID: <a href="/pubmed/20301709" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301709</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/alps/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/higes/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1537&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1537/?report=reader">PubReader</a></li><li><a href="/books/NBK1537/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1537" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1537" style="display:none" title="Cite this Page"><div class="bk_tt">Michelucci R, Nobile C. Autosomal Dominant Epilepsy with Auditory Features. 2007 Apr 20 [Updated 2019 Jan 10]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1537/pdf/Bookshelf_NBK1537.pdf">PDF version of this page</a> (523K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#peaf.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#peaf.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#peaf.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#peaf.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#peaf.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#peaf.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#peaf.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#peaf.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#peaf.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#peaf.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#peaf.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9211[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LGI1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5649[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RELN</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=64780[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MICAL1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1465698" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1465698" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1465698" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1465698" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30234941" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gertler T, Bearden D, Bhattacharjee A, Carvill G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301494" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miller IO, Sotero de Menezes MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301603" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang D, Pascual JM, De Vivo D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29763181" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simple Partial Seizure</a><span class="source">[StatPearls. 2019]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simple Partial Seizure<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kumar A, Sharma S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">StatPearls. 2019 Jan</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301348" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Nocturnal Frontal Lobe Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kurahashi H, Hirose S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301709" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301709" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc9499dde0891169db5027">Autosomal Dominant Epilepsy with Auditory Features - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Autosomal Dominant Epilepsy with Auditory Features - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:30:01-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE888EB0DFC89A810000000005570268&amp;ncbi_session=CE888EB0DFC94971_1367SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1537%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1537&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1537/&amp;ncbi_pagename=Autosomal Dominant Epilepsy with Auditory Features - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE888EB0DFC94971_1367SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>